[Improving adverse drug reaction reporting by general practitioners through clinical research assistants visits].

Therapie

Service de pharmacologie médicale et clinique, centre Midi-Pyrénées de pharmacovigilance, pharmacoépidémiologie et informations sur le médicament, pharmacopôle Midi-Pyrénées, faculté de médecine, CHU de Toulouse, 37, allées Jules-Guesde, 31000 Toulouse, France.

Published: June 2017

The main limitation of adverse drug reactions (ADRs) reporting, particularly by general practitioners (GP), to the regional pharmacovigilance centers is under-reporting. The Midi-Pyrénées Regional Pharmacovigilance Center (South western, France) sets up regular visits by a clinical research assistant (CRA) to GP in order to increase the number of ADR reports. The aim of this pilot study was to assess the effect of regular visits of a CRA in GPs offices on the rate of ADR reporting. After one year, CRA visits permit a two-fold increase in ADR reporting.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.therap.2016.09.004DOI Listing

Publication Analysis

Top Keywords

adverse drug
8
reporting general
8
general practitioners
8
regional pharmacovigilance
8
regular visits
8
adr reporting
8
[improving adverse
4
drug reaction
4
reporting
4
reaction reporting
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!